Publications by authors named "Roger Waltzman"

Claim this Profile
L
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.
Masoud F Tavazoie, Ilana Pollack, Raissa Tanqueco, Benjamin N Ostendorf, Bernardo S Reis, Roger J Waltzman

Cell· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.
Claire Harrison, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, Heinz Gisslinger, Roger Waltzman

N Engl J Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rates of durable response are achieved with imatinib after treatment with interferon alpha plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial.
François Guilhot, Brian Druker, Richard A Larson, Insa Gathmann, Charlene So, Roger Waltzman

Haematologica· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: long-term follow-up of the STI571 0102 and 0109 trials.
Richard T Silver, Jorge Cortes, Roger Waltzman, Manisha Mone, Hagop Kantarjian

Haematologica· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Ann Wexler, Anthony M Berson, Stephen E Goldstone, Roger Waltzman, Jason Penzer

Dis Colon Rectum· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Communicating about chemotherapy-induced anemia.
Brad Davidson, Diane Blum, David Cella, Heidi Hamilton, Lillian Nail, Roger Waltzman

J Support Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve.
Mei Sheng Duh, Patrick Lefebvre, John Fastenau, Catherine Tak Piech, Roger J Waltzman

Oncologist· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study to evaluate the safety and clinical outcomes of once-weekly epoetin alfa 80,000 u in anemic patients with cancer receiving chemotherapy.
Roger J Waltzman, Denise Williams, Patricia Braly

Support Cancer Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy.
Roger Waltzman, Christopher Croot, Glen R Justice, Mark R Fesen, Veena Charu

Oncologist· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing hematologic toxicities.
Gerardo Capo, Roger Waltzman

J Support Oncol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of chemotherapy-related anemia with erythropoietic agents: current approaches and new paradigms.
Roger J Waltzman

Semin Hematol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of mild anemia.
Roger J Waltzman

J Natl Compr Canc Netw· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.
Roger J Waltzman

Cancer· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis